Stockreport

FDA Grants Pediatric Disease Designation for Mateon’s OT101

MATEON THERAPEUTICS  (MATN) 
Last mateon therapeutics earnings: 11/19 05:25 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.mateon.com
PDF For treatment of diffuse intrinsic pontine glioma (DIPG), a difficult to treat form of childhood brain tumor AGOURA HILLS, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) - [Read more]